2024 annual financial data
Anika Therapeutics 2024 Financial results
Direct answer
Revenue was 119.91M USD.
Operating income was -5.1M USD and net income was -56.39M USD.
Operating cash flow was 5.4M USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 119.91M USD
- Operating income
- -5.1M USD
- Net income
- -56.39M USD
- Operating cash flow
- 5.4M USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Anika Therapeutics financial years